Performance of Pharmaceutical Company Lek in Ljubljana

Ljubljana, 18 November - LEK/OCVIRK/OPERATIONS
The performance of the Ljubljana pharmaceutical company Lek in the first nine months of 1997 follows the outlined economic plan for 1997, the head of the Management Board of the company Lek Andrej Ocvirk said. Lek made an income of SIT 32 billion by the sale of medicines, diagnostics, cosmetics, veterinary and dentistry products.

The rest of this news item is available to subscribers.
The news item consists of 917 characters (without spaces) or 176 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

pk/pk
© STA, 1997